Ironwood Pharmaceuticals Inc (IRWD) posted a 5.00% change over the last five days signaling a new trend

On Friday, Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) opened higher 15.32% from the last session, before settling in for the closing price of $19.83. Price fluctuations for IRWD have ranged from $8.07 to $14.98 over the past 52 weeks.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 4.99%. Company’s average yearly earnings per share was noted -709.38% at the time writing. With a float of $152.03 million, this company’s outstanding shares have now reached $154.03 million.

Ironwood Pharmaceuticals Inc (IRWD) Breakdown of a Key Holders of the stock

A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Ironwood Pharmaceuticals Inc is 2.63%, while institutional ownership is 104.84%. The most recent insider transaction that took place on Dec 14, was worth 111,072. In this transaction Director of this company sold 9,926 shares at a rate of $11.19, taking the stock ownership to the 96,572 shares. Before that another transaction happened on Nov 20, when Company’s SVP, Chief Business Officer sold 3,287 for $9.69, making the entire transaction worth $31,851. This insider now owns 217,374 shares in total.

Ironwood Pharmaceuticals Inc (IRWD) Recent Fiscal highlights

If we go through the results of last quarter, which was made public on 9/29/2023, the company posted $0.09 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at $0.16) by -$0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.15 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -709.38% per share during the next fiscal year.

Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Trading Performance Indicators

Check out the current performance indicators for Ironwood Pharmaceuticals Inc (IRWD). In the past quarter, the stock posted a quick ratio of 0.90. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.53. Likewise, its price to free cash flow for the trailing twelve months is 10.55.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.24, a number that is poised to hit 0.20 in the next quarter and is forecasted to reach 0.80 in one year’s time.

Technical Analysis of Ironwood Pharmaceuticals Inc (IRWD)

Compared to the last year’s volume of 3.41 million, its volume of 2.62 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 95.62%. Additionally, its Average True Range was 0.44.

During the past 100 days, Ironwood Pharmaceuticals Inc’s (IRWD) raw stochastic average was set at 99.70%, which indicates a significant increase from 99.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 21.73% in the past 14 days, which was lower than the 39.53% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $12.21, while its 200-day Moving Average is $10.54. Nevertheless, the first resistance level for the watch stands at $15.51 in the near term. At $15.69, the stock is likely to face the second major resistance level. The third major resistance level sits at $16.05. If the price goes on to break the first support level at $14.97, it is likely to go to the next support level at $14.61. Now, if the price goes above the second support level, the third support stands at $14.43.

Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Key Stats

There are currently 156,129K shares outstanding in the company with a market cap of 2.39 billion. Presently, the company’s annual sales total 410,600 K according to its annual income of 175,070 K. Last quarter, the company’s sales amounted to 113,740 K and its income totaled 15,320 K.